CytoQuel

Clinically researched CytoQuel has been developed to promote healthy cytokine activity. Based on the latest published research, CytoQuel is an effective new tool in the quest for healthy inflammation levels.

Current research has focused on the impact of pro-inflammatory cytokines on inflammation levels. During an infection, the body naturally produces pro-inflammatory cytokines as part of its defence mechanism. The healthy body balances pro-inflammatory cytokines with anti-inflammatory cytokines. However, if these pro-inflammatory cytokines (i.e. IL-1, IL-6, IL-8, IL-17, IL-23), Tumour Necrosis Factor-alpha (TNF-a), Nuclear Factor kappa Beta (NF-kß) continue in the “on position” and inflammation levels remain high, adverse health may be the result.